IV drugs are medications delivered directly into a vein through a needle or catheter, allowing them to enter the bloodstream immediately. Because they skip the digestive system entirely, IV drugs reach 100% bioavailability, meaning every bit of the dose makes it into circulation. This makes intravenous delivery the fastest and most complete way to get a medication working in the body.
How IV Drugs Work Differently
When you swallow a pill, it has to survive a long journey. It passes through your stomach, gets absorbed in your intestines, and then travels to your liver before reaching the rest of your body. At each step, some of the drug gets broken down or filtered out. The liver alone can convert a significant portion of an oral dose into inactive byproducts before the medication ever reaches the tissue it’s meant to treat. This process, called first-pass metabolism, is why oral drugs often need higher doses to compensate for what gets lost along the way.
IV drugs bypass all of that. A medication injected into a vein enters systemic circulation within seconds, which is why bioavailability is defined as 100% for the IV route. To put the speed difference in concrete terms: in one study comparing the same dose of a common pain reliever given orally versus intravenously, the IV version reached its peak blood concentration in about 15 minutes, while the oral version took a full hour. The IV peak was also nearly twice as high (21.6 micrograms per milliliter versus 12.3), meaning more of the drug was available to do its job at any given moment.
Why Medications Are Given by IV
Speed is the most obvious reason. In emergencies like severe allergic reactions, heart attacks, or dangerously high blood pressure, waiting an hour for a pill to kick in isn’t an option. IV delivery puts the drug to work almost immediately. Hospitals routinely use IV medications to manage acute hypertension, deliver chemotherapy, treat serious infections, replace fluids during dehydration, and provide pain relief during or after surgery.
Precision is the other major advantage. Because the full dose enters the bloodstream, doctors can calculate exactly how much of a drug a patient receives at any moment. Some medications also can’t survive the digestive tract at all. Stomach acid or liver enzymes would destroy them before they ever reached circulation, making IV the only viable route.
Bolus, Intermittent, and Continuous Infusion
Not all IV drugs are given the same way. The three main methods each serve a different purpose.
A bolus is a single dose pushed rapidly into the vein. It creates a fast, high peak of the drug in the blood. This is useful when you need an immediate effect, but the tradeoff is that drug levels spike and then drop off quickly. With some medications, those sharp peaks can increase side effects or even lead to the body developing a temporary tolerance, where a second dose becomes less effective because the kidneys compensate by holding onto more sodium or fluid.
A continuous infusion delivers medication at a slow, steady rate over hours or even days using an IV pump. This keeps drug levels in a narrow, consistent range, producing a more even effect. For example, when a heart-failure patient needs a diuretic to remove excess fluid, a continuous drip produces steady urine output throughout the infusion period. A bolus of the same drug would trigger aggressive fluid loss within the first two hours and then taper off.
An intermittent infusion falls between the two. A set dose is delivered over a defined period (often 30 to 60 minutes), repeated at scheduled intervals. Many antibiotics are given this way.
Types of IV Access
The simplest and most common setup is a peripheral IV line, a short, flexible catheter inserted into a vein in the hand or forearm. These are what you’ll see in most emergency rooms, outpatient clinics, and short hospital stays. In adults, peripheral lines are typically replaced every 72 to 96 hours to reduce the risk of infection and vein inflammation, though they may be removed sooner if problems develop.
When treatment requires weeks or months of IV access, or when the medications involved are too harsh for small veins, a central line is used instead. Central venous catheters are placed in larger veins, usually in the neck, chest, or upper arm, with the tip of the catheter sitting near the heart. One common type, a PICC line, is inserted through an arm vein and threaded into a central vein. PICC lines are often used for chemotherapy and long-term antibiotic courses and can stay in place for weeks to months. They’re also practical for patients receiving IV therapy at home. Central lines do carry risks: complication rates can reach up to 15% with traditional placement and include blood clots, infections, and mechanical problems.
Complications of Medical IV Therapy
Even in a clinical setting, IVs can cause local problems at the insertion site. The three most common are:
- Phlebitis: inflammation of the vein, causing redness, warmth, pain, and swelling that can track along the path of the vein. You may feel a firm, cord-like area under the skin.
- Infiltration: the catheter slips out of the vein or the vein wall leaks, sending fluid into the surrounding tissue. The skin around the IV site feels cool and tight, and the area swells. The IV may slow down or stop working.
- Extravasation: similar to infiltration, but involving a medication that damages tissue. In addition to swelling, you may notice burning, stinging, blistering, or in severe cases, tissue death around the site.
Any of these is a reason to alert a nurse immediately. The IV will be removed and, if needed, restarted in a different vein.
Risks of Non-Medical IV Drug Use
Outside of healthcare settings, injecting drugs intravenously carries a distinct and serious set of dangers. The combination of unsterile needles, shared equipment, and unregulated substances creates conditions for infections that range from treatable to fatal.
Bloodborne viruses are the most well-known risk. Nearly half of people who inject drugs test positive for hepatitis C, and the vast majority of new hepatitis C cases in countries like the UK occur in this population. HIV transmission through shared needles remains a concern as well, though rates vary widely by region.
Injection-site infections are extremely common. Roughly 28% of people who inject drugs report infections at their injection sites in a given year. These range from localized abscesses and skin infections to life-threatening conditions like necrotizing fasciitis (rapidly spreading tissue destruction) and sepsis. The bacteria most often responsible are staph and strep species, including MRSA.
The damage extends well beyond the skin. People who inject drugs face a tenfold increased risk of pneumonia compared to the general population and higher rates of tuberculosis. Infective endocarditis, a serious infection of the heart valves, is significantly more common in this group, with staph bacteria responsible for up to three-quarters of cases. Contaminated drug supplies have also caused outbreaks of rare infections, including anthrax and botulism. A 2000 outbreak linked to a single contaminated batch of heroin in Scotland killed 87% of confirmed cases.
These risks exist on top of the dangers of the drugs themselves, including overdose, vein damage, and the development of physical dependence.